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ABSTRACT
Aims: To determine the inhibitory effect of oral Lactobacillus against bacterial pathogens and investigate 
correlation between presence of Lactobacillus strains and health promotion.
Method: One hundred saliva samples were collected from oral cavity of domestic dairy consumers and 
were investigated for the isolation and identification of Lactobacillus strain by conventional culture and 
sequencing of 16SrRNA. Furthermore, well diffusion assay was performed to determination of antibac-
terial activity of Lactobacillus strains against bacterial pathogens including Salmonella typhimurium, Kleb-
siella pneumoniae, Shigella sonnei, Shigella dysenteriae, Enterococcus faecalis and Enterococcus faecium. Finally, 
association between health condition and isolation of Lactobacillus were investigated and obtained data 
using questionary form were analysed by chi-square test.
Results: Thirty Lactobacillus strains recovered from 100 hundred saliva samples. The 
most common isolated strain was L. gasseri (n=18) and followed by L. vaginalis (n=3) and 
L. salivarius (n=3). All Lactobacillus strains demonstrated antibacterial activity against at 
least one of the investigated pathogens. However, the strongest results were obtained by L. vaginalis 
against K. pneumonia. The correlation between the presence of thirty Lactobacillus strains and health pro-
motion not found. However, only L. gasseri species has significant positive impact on health in their hosts 
(P < 0.05).
Conclusion: Only some Lactobacillus species have a positive impact on health promotion. Despite of 
weak activity against the investigated pathogens, L. gasseri has a positive impact on the mental problem 
(intense anger and depression) of their hosts.
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ABSTRACT
Objetivos: Determinar el efecto inhibidor del Lactobacillus aislado de la cavidad oral contra patógenos 
bacterianos e investigar la correlación entre la presencia de cepas de Lactobacillus y la promoción de la 
salud.
Método: se recolectaron cien muestras de saliva de la cavidad oral de consumidores de productos lácteos 
y se investigó el aislamiento e identificación de la cepa de Lactobacillus mediante cultivo convencional y 
secuenciación de 16SrRNA. Además, se realizó un ensayo de difusión en pocillos para determinar la ac-
tividad antibacteriana de las cepas de Lactobacillus contra patógenos bacterianos que incluyen Salmonella 
typhimurium, Klebsiella pneumoniae, Shigella sonnei, Shigella dysenteriae, Enterococcus faecalis y Enterococcus 
faecium. Finalmente, se investigó la asociación entre el estado de salud y el aislamiento de Lactobacillus y 
se obtuvieron los datos utilizando el cuestionario mediante la prueba de chi-cuadrado.
Resultados: Se aislaron treinta cepas de Lactobacillus de 100 muestras de saliva. La cepa aislada más 
común fue L. gasseri (n = 18), seguida por L. vaginalis (n = 3) y L. salivarius (n = 3). Todas las cepas de 





Hossein Samadi Kafil  
PhD, Assistant professor
Department of Microbiology, Faculty of 






The authors declare that no funding 
whatsoever was received from any sour-
ce in carrying out the research work.
Agradecimientos 
Acknowledgements
This study was granted by Infectious 
and Tropical Diseases Research Center, 
Tabriz University of Medical Sciences 
and approved by Tabriz University of 
Medical Sciences. Authors would like to 
thank all staff of Biomedicine (Medical 
Biology) Research Institute.
This study was supported by Infectious 
and Tropical Diseases Research Center, 
Tabriz University of Medical Sciences. 
We would like to thank all participants 
and DARC center for their collaboration.
Conflicto de interés 
Competing interest




This study has no results of experimen-
tal studies on human participants or 
use of laboratory animals, therefore no 
Ethical approve is required.
Received: 15.09.2018 
Accepted: 08.02.2019
Inhibitory effect of isolated Lactobacillus from oral cavity against 
bacterial Pathogens and its effect on health promotion
Efecto inhibidor de Lactobacillus aislado de la cavidad oral contra patógenos bacte-
rianos y su efecto en la promoción de la salud
Khalil Azizian1,2, 3, Sepehr Taghizadeh1, Rasoul Hosseinpour3, Asghar Tanomand4, Elham Sheykhsaran1, Naser 
Alizadeh2, Behrooz Naghili1, Hossein Samadi Kafil1,*
1. Infectious and Tropical Diseases Research Center, Tabriz university of medical science, Tabriz, Iran.
2. Department of Medical Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
3. Liver and Gastrointestinal Diseases Research Center, Tabriz university of medical science, Tabriz, Iran.
4. Department of Basic Sciences, Maragheh University of Medical Sciences, Maragheh, Iran.
http://dx.doi.org/10.30827/ars.v60i1.7943
28 Ars Pharm. 2019; 60(1): 27-33
Azizian K, et al.
Sin embargo, los resultados más fuertes fueron obtenidos por L. 
vaginalis contra K. pneumonia. No se encontraron correlación entre 
la presencia de algunas de las treinta cepas de Lactobacillus y la 
promoción de la salud. Sin embargo, solo la especie L. gasseri tuvo 
un impacto positivo significativo en la salud de sus hospedadores 
(P <0,05).
Conclusión: solo algunas especies de Lactobacillus tienen un im-
pacto positivo en la promoción de la salud. A pesar de la actividad 
débil contra los patógenos investigados, L. gasseri tiene un impacto 
positivo en el problema mental (ira intensa y depresión) de sus 
huéspedes.
Palabras clave: Lactobacillus; condición de salud; actividad antibac-
teriana; cavidad oral.
INTRODUCTION
In the past decade role of probiotic microorganisms in 
health promotion and as preventative agents were inves-
tigated 1,2. Probiotics described as microorganisms which 
are useful if used in sufficient number 3,4. Different bacteria 
such as Bifidobacterium, Streptococcus, and Lactobacillus in-
troduced as probiotics, and known as generally recognized 
as safe (GRAS) and non-pathogenic bacteria 3,5,6. Recently, 
Lactobacillus spp. considered as main probiotic in medical 
and industrial scope1,2. Lactobacillus spp. are heterogeneous 
group of bacteria including about 145 species of non-spore 
forming and Gram-positive rods which can be grown in 
anaerobic or microaerophilic conditions3. Also, Lactobacil-
lus was used in dairy and fermented food for promotion 
of health quality 3. However, Lactobacillus spp. is presented 
in various places like environment and human body (oral 
cavity, gastrointestinal and vaginal tract) 1,2,5,7.
It was previously demonstrated that consumption of Lacto-
bacillus has several benefits including decrease of time and 
severity of diarrhea 3, antibacterial and antifungal charac-
teristics 8, and improvement of vaginal health 7.
Inhibitory activity against the pathogens is one of the most 
characteristics of bacteria which known as probiotics. Pro-
biotic inhibitory activity is related to reduce of pathogenic 
colonization and causing adverse growth conditions for 
pathogens by production of hydrogen peroxide (H2O2) 
and bacteriocin 8-10. Moreover, it has recently been demon-
strated that Lactobacillus species isolated from human are 
better probiotics, because these strains were adapted to the 
human body and also exposure to antibiotics in this place 
is less than other origins 11.
In recent years, the role of oral microbiome in health qual-
ity was discussed extensively. Some studies demonstrated 
correlation between dental caries, oral cancer and inflam-
mation caused by oral microbiome 6,12,13. But other study 
indicated that available Lactobacillus spp. in the oral cavity 
have useful role in promotion of oral and gastrointestinal 
health 4.
The milk products including yogurt and cheese are im-
portant dietary supplements which contain Lactobacillus 
14. Consumption of these products is main way to probi-
otic transmission to the host body. Thus, there is probably 
strong association between diet and commensal microor-
ganism including probiotics bacteria 15.
The aims of this study were investigate the inhibitory activ-
ity of isolated Lactobacillus from oral cavity and also, deter-
mination of association between isolation rates of Lactoba-
cillus and health quality in the host.
MATERIAL AND METHODS
Study population
One hundred healthy persons who use domestic dairy 
products were recruited in this study. The study was con-
ducted from May to August 2017 at rural area of Bukan, 
Western Azerbaijan province, Iran. Also, the questioner 
forms were applied to all persons. These forms were in-
cluded age, gender, experience of infectious disease, severe 
gastric pain, herpes, and mental problem (intense anger 
and depression). The current study was approved by the 
Research Ethics Committee of Tabriz University of Medical 
Science; also signed informed consent form was obtained 
from each patient prior to the initiation of sampling. Par-
ticipants were subjected for sampling without any haz-
ardous action and participation was completely volunteer. 
This research has been conducted in full accordance with 
the World Medical Association Declaration of Helsinki and 
was done after confirmation of ethic committee of Tabriz 
University of medical sciences.
Sample collection
According to Kohler and Bratthall (1979), sample collec-
tion was performed by modified spatula method 16. Briefly, 
wooden spatula was inserted in oral cavity to moisten it 
with saliva. Then both sides of spatula placed on Rogosa SL 
agar (MicroMaster, India). The plates were incubated under 
anaerobic condition (80% N2, 10% H2, and 10% CO2) pro-
vided by Anoxomat (Mart Microbiology BV) at 37°C for 72 
h. Then dominant Lactobacillus colonies were selected and 
stored to further analysis.
Isolation and identification
The suspected colonies, temporary identified as Lactoba-
cillus spp. based on phenotypically tests including colony 
morphology, wet mount smear, Gram staining, and catalase 
negative reaction17. DNA extraction was applied by boiling 
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method as previously described 18,19. Amplification and se-
quencing of 16SrRNA was performed to confirmation of 
Lactobacillus spp. PCR amplification was performed by the 
following primers: Forward 5-CTCGTTGCGGGACTTAA-3 
and Reverse 5 -GCAGCAGTAGGGAATCTTC-3 (Bioneer, 
Korea) 4. The PCR amplification was performed in a total 
volume of 50 µL containing 25 µL master kit (Ampliqon, 
Denmark), 5 pmol of each primer and 15 ng DNA. The PCR 
proceed using a DNA thermal cycler (Master Cycle Gradi-
ant, Eppendrof, Germany) programmed with initial 94°C 
for 5 min and followed by 35 cycles of 94°C for 30 s, 56°C 
for 50s and 72°C for 1 min, and with additional extension 
at 72°C for 10 min. PCR products were electrophoresis in 
1.5% agarose gel and after staining with Safestain (Yekta 
tazhiz, Iran) visualized under UV light 20. All PCR products 
were subjected to sequencing by Bioneer (South Korea). 
Finally obtained sequences were compared with available 
sequences in GeneBank (www.ncbi.nlm.nih.gov/blast).
Antimicrobial activity
According to earlier study 4, agar well diffusion method 
was performed to determination of Lactobacillus spp. an-
tibacterial activity against various pathogenic bacteria. In 
fact, bacteriocin effect against growth of S. typhimurium, K. 
pneumoniae, S. sonnei, S. dysenteriae, Enterococcus faecalis and 
Enterococcus faecium was determinate using agar well diffu-
sion assay. For this reason, the Lactobacillus spp. were in-
cubated at anaerobic condition in MRS broth (37°C for 24h). 
Then, cell free supernatant was prepared by centrifugation 
at 10,000 g for 10 min 4,21.
Different antibacterial compound including organic acid 
and bacteriocin are produced by Lactobacillus. To remove 
of the organic acid effect against pathogenic bacteria, pH of 
supernatant should be neutralized with NaOH (2.5M) and 
catalase (1 mg/ml, Sigma Aldrich, Germany), respectively 
4.
Briefly, then 0.5 McFarland was prepared for each pathogen 
and cultured on MHA (MicroMaster, India). Then 100mL 
of cell free neutralized supernatant was inoculated in wells 
and incubated at 37°C for 24 h. Finally Lactobacillus with 
clear zones <11 mm, 11-16, 17-22 and >22 described as 
negative (-), mild (+), strong (++), and very strong (+++) 
inhibitor, respectively. The sterile MRS broth was used as 
negative control 4.
Statistical analysis
Data analysis was performed using SPSS 23 software (SPSS 
Inc., IL, USA). Moreover, obtained data were analysed via 
chi-square test. Differences were considered to be statisti-
cally significant when P value was less than 0.05.
RESULT
Demographic data
In this study, one hundred oral salivary samples were in-
vestigated. Demographic data were demonstrated in Table 
1. Among one hundred persons, 49 and 51 of them were 
male and female respectively, with mean age 36+43 years 
(6-81 years). Lactobacillus strains were isolated from 30 
persons including 16 males and 14 females. Mean age in 
these persons were 34+27 years. The correlation between 
Lactobacillus isolation and evaluated factors (age, gender, 
natural or cesarean born, the experience of severe infec-
tion disease, herpes infection and gastric pain, and mental 
problem including intense anger and Depression) were not 
significant. In the other hand, the incidence of the mental 
problems in eighteen host L. gasseri significantly was low 
(4/18) compared to Lactobacillus-negative persons (40/70) 
(P < 0.05).
Table 1. Demographic data of persons enrolled in this study
Lactobacillus positive (30) Lactobacillus negative (70) Total (100) P value
Gender (male) 16 33 49 0.363
Mean age (years) 34.27 37.36 36.43
Natural born 28 66 94 0.585
Infection disease * 8 19 27 0.584
Gastric pain * 10 20 30 0.401
Mental problem * 12 40 52 0.088
Herpes infection * 17 41 58 0.516
*: number of persons that experience severe infection disease, Gastric pain, mental problem and Herpes infection
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Lactobacillus spp.
Totally, thirty Lactobacillus were isolated by phonotypical 
assay and also, confirmation was performed by PCR and 
sequencing of 16S rRNA gene. From 30 Lactobacillus spp. 
eighteen isolates (60%) was identified as L. gasseri. Other 
isolates were L. vaginalis (n=3), L. salivarius (n=3), L. crispa-
tus (n=2), L. curvatus (n=1), L. fermentum (n=1), L. kitasatonis 
(n=1) and L. panis (n=1).
Antimicrobial activity
The growth inhibitory activity against S. typhimurium 
ATCC® 14028™, K. pneumonia ATCC® 13883™, S. sonnei 
ATCC® 25931™, S. dysenteriae ATCC® 11835™, E. faecalis 
ATCC® 29212™ and E. faecium ATCC® 19434™ was illus-
trated in Table 2. Of the 30 Lactobacillus only three isolates 
of them were included two L. vaginalis and one L. kitasa-
tonis demonstrate ++ and +++ inhibitory zone. These iso-
lates have inhibitory zone 17-22 mm and more than 23 mm 
against K. pneumonia. Thus, K. pneumonia was the most 
susceptible investigated species. In fact L. vaginalis was the 
strain of Lactobacillus that demonstrates strongest activity 
against K. pneumonia.
Table 2. Antimicrobial activity of cell-free culture supernatants of lactobacillus isolates
Bacterial isolates















- 15 10 12 11 7 18
+ 3 8 6 7 11 0
L. vaginalis (3)
- 2 2 3 1 3 3
+ 1 1 - - 0 -
++ - - - 1 - -
+++ - - - 1 - -
L. salivarius (3)
- - - 3 - 3 3
+ 3 3 - 3 - -
L. crisptus (2)
- 2 1 2 1 2 2
+ - 1 - 1 - -
L. curvtus (1)
- 1 - 1 - 1 1
+ - 1 - 1 - -
L. panis (1)
- 1 - 1 - 1 1
+ - 1 - 1 - -
L. fermantus (1)
- 1 - 1 1 - 1
+ - 1 - - 1 -
L. kitasatonis (1)
- 1 - 1 - 1 1
+ - 1 - - - -
++ - - - 1 - -
Antibacterial activity was determined using agar well diffusion assay. Interpretation of Inhibitory range, - : <11 mm (negative); +: 11-16 
mm (mild); ++: 17-22 mm (strong); +++: ≥ 23 (very strong).
31Ars Pharm. 2019; 60(1): 27-33
Inhibitory effect of isolated Lactobacillus from oral cavity against bacterial Pathogens and its effect on health promotion
DISCUSSION
The probiotics bacteria were used for promotion and preser-
vation of health quality for decades 5. Lactobacillus species 
are the most well-known probiotics and the important con-
stituent of human body flora including oral, intestinal and 
vaginal tract 5. One of the main ability of probiotics is host 
protection against pathogen microorganisms like as Salmo-
nella, Shigella and other invasive pathogens 1,22,23. The pre-
vious study indicated that, in pregnant women which use 
from oral probiotics, colonization of Group B Streptococcus 
was reduced in rectal and vaginal tracts 9. Along with listed 
their advantages, results of previous studies demonstrated 
possible association of some Lactobacillus species with host 
unfavorable conditions like as dental caries and glycaemia 
in human 5,24.
In different studies, Lactobacillus species isolated from oral 
cavity were diverse. In the current study, like of previous 
studies L. gasseri, L. salivarius, and L. vaginalis were isolat-
ed from oral cavity 11,25. But predominant isolates recovered 
from oral cavity in different studies were diverse too. In 
agreement reported paper 26 results of this study demon-
strated that, L gasseri was the predominant isolated strain, 
while in other studies performed by Strahinic et al. and 
Ahirwar et al, L. rhamnosus and L. fermentum introduced as 
predominant recovered strains, respectively 25,27. It is likely 
that main reasons related to this diversity are oral health 
and wealth condition, diet, kind of samples (saliva or den-
tal plaque), the age of patient and performed methods to 
species identification. For example, in contrast with an 
earlier study, in this study PCR and sequencing of 16SrR-
NA (the most reliable method) was performed for species 
identification and confirmation 27. Also, Piwat et al (2010) 
demonstrated that L. plantarum and L. mucosae were recov-
ered in patients with moderate to high dental caries, but the 
most frequent species in the low-dental caries group were 
L. gasseri, L. vaginalis, and L. oris 6. However, in accordance 
with this study, previously reported literature illustrated 
that, in contrast with dental samples in oral saliva, L gasseri 
was predominant isolated strain 26.
In agreement with previous works, this report demonstrat-
ed that Lactobacillus strains were able to inhibit the growth 
of enteropathogen bacteria 9,28. In accordance with previous 
study, among the tested Enterobacteriaceae, S. typhimurium 
were the most resistant species against CFS of L. gasseri 29. 
The previous study performed by Koga et al. demonstrated 
that L. gasseri was unable to inhibit growth of Salmonel-
la species, while in current study few strains of L. gasseri 
isolates were able to inhibit growth of Enterobacteriaceae in-
cluding S. sonnei (6/18), S. dysenteriae (8/18), K. pneumoniae 
(7/18) and S. typhimurium (3/18). This diversity is related 
to several factors including isolation origin, performed 
methods and applied Lactobacillus species. For example, 
Lactobacillus strains with oral and gastrointestinal origin 
are more effective against Enterobacteriaceae compared to 
strains with other origins. This is related with the high ad-
aptability of Lactobacillus strains.
Previously showed that antibacterial activities of Lactoba-
cillus strains against S. typhimurium is related to production 
of different compounds which inhibit motility and penetra-
tion of these bacteria into enterocyte-like Caco-2/TC7 cells 
30.
The Lactobacillus strains have wide range of inhibitory 
growth effect from absent to very strong against Enterococ-
cus species. Shim et al. (2016) demonstrated mild inhibition 
effect against E. fecalis 31. But in this work, none of Lactoba-
cillus isolates were able to inhibit growth of E. fecalis, while 
61% of L. gasseri isolates demonstrate mild inhibitory effect 
against E. faecium.
In agreement study performed by Zhang et al. (2001), the 
current work showed that growth of Salmonella was inhib-
ited by treatment of L. salivarius culture supernatants 32.
Until now, different studies discussed the impact of Lacto-
bacillus genus on protection and promotion of the human 
health. Some studies illustrated beneficial effect on human 
health, but in contrast, some studies have not found these 
impacts and rejected this theory 22,24,33. For example, an ear-
lier study demonstrated relation of dental caries and the 
prevalence of Lactobacillus strain in oral cavity 5. Their 
ability of acid production by Lactobacillus was expressed 
for dental caries 5. In disagreement this statement, some 
studies demonstrated that oral health was promoted due 
to presence of Lactobacillus, and this is related to activity 
of Lactobacillus against cariogenic Streptococcus, and peri-
odontal pathogens 1,5,34.
In this study, any relation between the presence of Lac-
tobacillus and investigated health factors was observed. 
However, interestingly in accordance with other studies, 
presence of L. gasseri is contributed to health promotion in 
current study 9,35,36. This contradictory result is related to 
the investigated species and showed that L. gasseri has a 
positive impact on human health in comparison to other 
species. Until now, it is difficult to explain how the Lacto-
bacillus strains have effects on host health.
In summary: in this study, most Lactobacillus strains iso-
lated from oral cavity able to inhibit growth of gastrointes-
tinal pathogens. This ability is related to high adaptability 
of Lactobacillus strains. Moreover, non-association between 
the presence of different Lactobacillus species and investi-
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gated health factors was observed. However, only L. gasseri 
has a positive impact on the mental problem (intense anger 
and depression) of their hosts. These results indicated that 
only some species of Lactobacillus genus has the positive 
impact on their host.
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